Core Scientific

CORZ

Market cap $4.68B

AUSTIN, Texas--(BUSINESS WIRE)--Core Scientific, Inc. (Nasdaq: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for high-density colocation, today announced that it completed the initial closing of a $500 million 364-day loan facility (the “Facility”) provided by Morgan Stanley. The Facility includes an accordion feature that provides the potential to increase total commitments by up to an additional $500 million, for total commitments of up to $1.0 billion, subjec.

Clearline Capital LP bought 3,436,127 shares of Core Scientific; estimated transaction value $59.91 million (based on average price for the quarter) Quarter-end position value increased $45.79 million, reflecting both trading and price appreciation Trade size represented 2.96% of 13F AUM Post-trade holding: 4,689,443 shares, valued at $68.28 million The position now accounts for 3.37% of reportable AUM, placing it outside the fund's top five holdings

CORZ is positioned for significant margin expansion and top-line growth from FQ1'26 onwards, based on the guidance of ~$850M annual revenue and 75–80% gross margins from CRWV contracts. Despite the cooling AI sentiment, the capex-light model and strong industry tailwinds support the Bitcoin miner turned HPC provider's growth prospects. CORZ's growth-to-valuation profile is attractive post-correction, with FY2026 EV/Sales at 7.91x and projected 3Y revenue growth CAGR of +62.9% outpacing most peers.

Core Scientific's NASDAQ: CORZ stock price struggles with traction in early 2026, but don't be fooled. The company's strategic shift from Bitcoin mining to AI mining is gaining traction and accelerating, and it is on track for robust, profitable growth in the coming years.

Core Scientific Inc. (NASDAQ: CORZ) reported a fourth-quarter adjusted loss of 29 cents, missing the consensus of 18 cents.

Iran crypto withdrawals spike amid U.S., Israel military operation. These miners tumble on plans to sell bitcoin holdings.

Core Scientific, Inc. (CORZ) Q4 2025 Earnings Call Transcript

Although the revenue and EPS for Core Scientific, Inc. (CORZ) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Core Scientific, Inc. (CORZ) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.01 per share a year ago.

If you've been following the market over the last few months, you know it's become bifurcated into winners and losers, and the losers are feeling serious pain.